PDF herunterladen
Ultraschall Med 2024; 45(02): 199
DOI: 10.1055/a-2150-8253
Letter to the Editor

Wegweiser auffälliger NIPT

Artikel in mehreren Sprachen: English | deutsch
Karl-Oliver Kagan
1   Obstetrics and gynaecology, University Hospital Tuebingen, Tuebingen, Germany
,
Renate Rosenberg
2   Practice for prenatal medicine, Münster, Germany
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Cell-free DNA analysis of maternal blood (cfDNA test or NIPT) is a screening test with high test performance regarding screening for trisomy 21, 18 and 13. Nevertheless, the plausibility of each result should be critically reviewed. This applies in particular to abnormal findings. The DEGUM has developed a recommendation for this situation to support attending physicians.

The following five aspects should be considered when dealing with an abnormal NIPT result:



Publikationsverlauf

Eingereicht: 05. August 2023

Angenommen: 08. August 2023

Accepted Manuscript online:
08. August 2023

Artikel online veröffentlicht:
08. Februar 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany